Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

BSX Boston Scientific Corporation

88,95

0,29 (0,33%)

21 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/21/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Edward Ludwig

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Boston Scientific (NYSE:BSX)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Boston Scientific Charts.

Boston Scientific (NYSE:BSX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Boston Scientific Charts.

News Boston Scientific Corporation

Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace
Mittwoch 11 Dezember 2024 (2 Wochen vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 4 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 2 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 2 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 27 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 26 November 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 25 November 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 25 November 2024 (4 Wochen vor) • Edgar (US Regulatory)

Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.
Montag 25 November 2024 (4 Wochen vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 22 November 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 22 November 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 21 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere Boston Scientific Corporation News-Artikel

Deutsche Lufthansa

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen